Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Supply of crisis-relevant medical countermeasures in the event of a public health emergency at the European Union level

Supply of crisis-relevant medical countermeasures in the event of a public health emergency at the European Union level

 

SUMMARY OF:

Regulation (EU) 2022/2372 on a framework of measures for ensuring the supply of crisis-relevant medical countermeasures in the event of a public health emergency at the European Union level

WHAT IS THE AIM OF THE REGULATION?

It sets out a framework of measures to be activated in the event of a public health emergency, enabling the European Union (EU) to take the necessary measures for a sufficient and timely availability and supply of crisis-relevant medical countermeasures.

KEY POINTS

Health preparedness and response

Scope

The regulation sets out an emergency framework in the event of a public health emergency. The following measures may be activated:

  • setting up a Health Crisis Board;
  • monitoring, procurement and purchase of crisis-relevant medical countermeasures and crisis-relevant raw materials;
  • the activation of emergency research and innovation plans, including the use of EU-wide clinical trial networks and data-sharing platforms;
  • emergency EU funding;
  • measures concerning the production, availability and supply of crisis-relevant medical countermeasures – this includes establishing an inventory of crisis-relevant production and production facilities, crisis-relevant raw materials, consumables, equipment and infrastructure, along with measures to increase their production in the EU.

Activation

  • In the event of a public health emergency at the EU level, the Council, upon the proposal from the Commission, may adopt a regulation activating the emergency framework where it is appropriate to the economic situation.
  • The framework is activated for 6 months but can be prolonged.

Health Crisis Board

  • If emergency measures are activated, a Health Crisis Board will coordinate actions by the Council, the Commission, the relevant EU bodies, offices and agencies, and EU Member States to ensure the supply of and access to crisis-relevant medical countermeasures.
  • The Board will be composed of the Commission and one representative from each Member State.
  • The Commission must consult the Board whenever possible before taking action and report back to the Board on the action taken.

FROM WHEN DOES THE REGULATION APPLY?

It has applied since 26 December 2022.

BACKGROUND

For further information, see:

MAIN DOCUMENT

Council Regulation (EU) 2022/2372 of 24 October 2022 on a framework of measures for ensuring the supply of crisis-relevant medical countermeasures in the event of a public health emergency at Union level (OJ L 314, 6.12.2022, pp. 64–78).

RELATED DOCUMENTS

Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on serious cross-border threats to health and repealing Decision No 1082/2013/EU (OJ L 314, 6.12.2022, pp. 26–63).

Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control (OJ L 142, 30.4.2004, pp. 1–11).

Successive amendments to Regulation (EC) No 851/2004 have been incorporated into the original text. This consolidated version is of documentary value only.

Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (OJ L 20, 31.1.2022, pp. 1–37).

Commission Decision of 16 September 2021 establishing the Health Emergency Preparedness and Response Authority (OJ C 393 I, 29.9.2021, pp. 3–8).

Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions: Drawing the early lessons from the COVID-19 pandemic (COM(2021) 380 final, 15.6.2021).

Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: Pharmaceutical Strategy for Europe (COM(2020) 761 final, 25.11.2020).

Council Regulation (EU) 2016/369 of 15 March 2016 on the provision of emergency support within the Union (OJ L 70, 16.3.2016, pp. 1–6).

See consolidated version.

Decision No 1313/2013/EU of the European Parliament and of the Council of 17 December 2013 on a Union Civil Protection Mechanism (OJ L 347, 20.12.2013, pp. 924–947).

See consolidated version.

Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, pp. 1–33).

See consolidated version.

last update 26.12.2022

Top